Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10226
CALL
Brady Corp
BRC
$4B
| $222K | ﹤0.01% |
3,000
+1,900
| +173% | +$141K |
2022 Q4
8 quarters
|
|
10227
PUT
Apogee Enterprises
APOG
$848M
| $221K | ﹤0.01% |
3,100
-2,900
| -48% | -$228K |
2020 Q2
18 quarters
|
|
10228
BlackRock Capital Allocation Term Trust
BCAT
$1.46B
| $221K | ﹤0.01% |
+14,611
| New | +$235K |
2024 Q4
0 quarters
|
|
10229
PUT
Kymera Therapeutics
KYMR
$9.35B
| $221K | ﹤0.01% |
5,500
-9,700
| -64% | -$438K |
2022 Q3
9 quarters
|
|
10230
PUT
Janus Henderson B-BBB CLO ETF
JBBB
$1.51B
| $221K | ﹤0.01% |
4,500
-100
| -2% | -$4.92K |
2024 Q3
1 quarter
|
|
10231
PUT
Castle Biosciences
CSTL
$1.05B
| $221K | ﹤0.01% |
8,300
+2,400
| +41% | +$73.1K |
2024 Q2
2 quarters
|
|
10232
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.71B
| $221K | ﹤0.01% |
8,637
-55,468
| -87% | -$1.44M |
2024 Q3
1 quarter
|
|
|
OBE
10233
PUT
Obsidian Energy
OBE
$742M
| $221K | ﹤0.01% |
38,100
+7,500
| +25% | +$42.8K |
2022 Q2
10 quarters
|
|
10234
HF Foods Group
HFFG
$87.9M
| $221K | ﹤0.01% |
68,696
+40,377
| +143% | +$141K |
2024 Q1
3 quarters
|
|
10235
PUT
Bioventus
BVS
$892M
| $221K | ﹤0.01% |
21,000
-20,400
| -49% | -$241K |
2023 Q2
6 quarters
|
|
10236
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$48M
| $220K | ﹤0.01% |
3,700
+2,100
| +131% | +$139K |
2023 Q3
5 quarters
|
|
10237
Matrix Service
MTRX
$298M
| $220K | ﹤0.01% |
18,411
-20,429
| -53% | -$250K |
2022 Q4
8 quarters
|
|
10238
ProShares Ulta SmallCap600
SAA
$25.5M
| $220K | ﹤0.01% |
+8,481
| New | +$238K |
2024 Q4
0 quarters
|
|
10239
IonQ
IONQ
$16.2B
| $220K | ﹤0.01% |
5,259
-952,899
| -99% | -$23.9M |
2024 Q3
1 quarter
|
|
10240
Kaltura
KLTR
$201M
| $220K | ﹤0.01% |
99,813
+10,616
| +12% | +$19.4K |
2023 Q1
7 quarters
|
|
10241
iShares US Small Cap Value Factor ETF
SVAL
$158M
| $220K | ﹤0.01% |
+6,759
| New | +$227K |
2024 Q4
0 quarters
|
|
10242
Amtech Systems
ASYS
$288M
| $219K | ﹤0.01% |
40,256
-2,040
| -5% | -$11.6K |
2022 Q3
9 quarters
|
|
10243
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$33.8M
| $219K | ﹤0.01% |
+5,764
| New | +$222K |
2024 Q4
0 quarters
|
|
10244
PUT
Werner Enterprises
WERN
$1.96B
| $219K | ﹤0.01% |
6,100
+800
| +15% | +$30.6K |
2021 Q3
13 quarters
|
|
10245
WisdomTree Bitcoin Fund
BTCW
$190M
| $219K | ﹤0.01% |
2,221
-6,538
| -75% | -$576K |
2024 Q1
3 quarters
|
|
|
CMRC
10246
CALL
Commerce.com Inc Series 1
CMRC
$288M
| $219K | ﹤0.01% |
35,800
-2,300
| -6% | -$14.4K |
2020 Q3
17 quarters
|
|
10247
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$248M
| $219K | ﹤0.01% |
3,387
-40,956
| -92% | -$2.66M |
2023 Q2
6 quarters
|
|
10248
PUT
Avita Medical
RCEL
$409M
| $219K | ﹤0.01% |
17,100
-20,800
| -55% | -$245K |
2022 Q3
9 quarters
|
|
10249
CALL
iShares Residential and Multisector Real Estate ETF
REZ
$782M
| $219K | ﹤0.01% |
2,700
-4,000
| -60% | -$343K |
2021 Q2
14 quarters
|
|
10250
PUT
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.18B
| $219K | ﹤0.01% |
+5,400
| New | +$228K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.